Free Trial

Neurogene (NGNE) Insider Trading & Ownership

Neurogene logo
$22.39 -2.18 (-8.87%)
(As of 12:25 PM ET)

Neurogene (NASDAQ:NGNE) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
9.92%
Number Of
Insiders Buying
(Last 12 Months)
3
Amount Of
Insider Buying
(Last 12 Months)
$2.72 M
Number Of
Insiders Selling
(Last 12 Months)
0
Get NGNE Insider Trade Alerts

Want to know when executives and insiders are buying or selling Neurogene stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

NGNE Insider Buying and Selling by Quarter

Neurogene Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
11/26/2024Samsara Biocapital Gp, LlcMajor ShareholderBuy48,770$25.83$1,259,729.10  
11/22/2024Christine Mikail CvijicCFOBuy24,000$20.48$491,520.00  
11/22/2024Rachel McminnCEOBuy47,500$20.40$969,000.00  
(Data available from 1/1/2013 forward)

NGNE Insider Trading Activity - Frequently Asked Questions

The list of insiders at Neurogene includes Christine Mikail Cvijic, Rachel Mcminn, and Samsara Biocapital Gp, Llc. Learn more on insiders at NGNE.

9.92% of Neurogene stock is owned by insiders. Learn more on NGNE's insider holdings.

The following insiders have purchased NGNE shares in the last 24 months: Christine Mikail Cvijic ($491,520.00), Rachel Mcminn ($969,000.00), and Samsara Biocapital Gp, Llc ($1,259,729.10).

Insiders have purchased a total of 120,270 NGNE shares in the last 24 months for a total of $2,720,249.10 bought.

Neurogene Key Executives

  • Dr. Rachel L. McMinn Ph.D. (Age 51)
    Founder, Executive Chair & CEO
    Compensation: $676.54k
  • Ms. Christine Mikail Cvijic J.D. (Age 46)
    President, CFO & Corporate Secretary
    Compensation: $623.29k
    1 recent trades
  • Dr. Stuart Cobb Ph.D. (Age 54)
    Chief Scientific Officer
    Compensation: $478.81k
  • Mr. Arvind Sreedharan
    Senior Vice President of Business Operations
  • Ms. Donna M. Cochener-Metcalfe J.D. (Age 49)
    Senior VP & General Counsel
  • Dr. Effie Albanis M.D.
    Senior Vice President of Early Clinical & Translational Research
  • Dr. Andrew E. Mulberg CPI
    FAAP, M.D., Senior Vice President of Regulatory Affairs, Quality Assurance & Quality Control
  • Mr. Ricardo Jimenez
    Senior Vice President of Technical Operations
  • Dr. Julie Jordan M.D. (Age 52)
    Chief Medical Officer


This page (NASDAQ:NGNE) was last updated on 12/3/2024 by MarketBeat.com Staff
From Our Partners